In Pulmonary arterial hypertension (PAH) Pulmonary arterial hypertension can cause shortness of breath, tiredness, dizziness, chest pain and swelling in your ankles and legs. It is caused by thickening of walls of the arteries that supply your lungs making it hard for blood to get through. Pulmonext 10 Tablet relaxes the blood vessels and can help lower the blood pressure in the arteries of your lungs. You will be able to carry out your daily activities more easily and feel less tired or dizzy.
It is not known whether it is safe to consume alcohol with Pulmonext 10 Tablet. Please consult your doctor.
Pulmonext 10 Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Information regarding the use of Pulmonext 10 Tablet during breastfeeding is not available. Please consult your doctor.
Pulmonext 10 Tablet may cause dizziness or weakness due to low blood pressure. Do not drive if these symptoms occur.
Pulmonext 10 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Pulmonext 10 Tablet may be needed. Please consult your doctor. Limited information is available on use of Pulmonext 10 Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Pulmonext 10 Tablet should be used with caution in patients with liver disease. Dose adjustment of Pulmonext 10 Tablet may be needed. Please consult your doctor.
If you miss a dose of Pulmonext 10 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)